Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.

Sinakos, Emmanouil; Marschall, Hanns-Ulrich; Kowdley, Kris V; Befeler, Alex; Keach, Jill; Lindor, Keith

Sinakos, Emmanouil; Marschall, Hanns-Ulrich; Kowdley, Kris V; Befeler, Alex; Keach, Jill; Lindor, Keith.

Affiliation

Sinakos E; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

Hepatology ; 52(1): 197-203, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20564380

Subject(s)

Bile Acids and Salts/blood; Cholagogues and Choleretics/administration & dosage; Cholangitis, Sclerosing/drug therapy; Ursodeoxycholic Acid/administration & dosage; Adolescent; Adult; Aged; Cholagogues and Choleretics/blood; Cholangitis, Sclerosing/blood; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lithocholic Acid/blood; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid/blood; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ursodeoxycholic Acid / Bile Acids and Salts / Cholagogues and Choleretics / Cholangitis, Sclerosing Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hepatology Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google